MedTrace Logo

Mechanism of Class II Correction With Fixed Lingual Mandibular Growth Modificator (FLMGM)

NCT01853995 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2014-04-17

No results posted yet for this study

Summary

The aim of the current controlled trial was to assess the possible net skeletal and dental effects of FLMGM treatment in relation to growth with emphasis on the contribution of skeletal and dental changes to sagittal correction of Cl II/1 malocclusion.

The null hypothesis stated that there were no significant differences in dentoskeletal changes between FLMGM treated group and control untreated group.

Conditions

  • Class II Division 1 Malocclusion

Interventions

DEVICE

Fixed Lingual Mandibular Growth Modificator (FLMGM)

New Class II Corrector

Sponsors & Collaborators

  • Damascus University

    lead OTHER

Principal Investigators

  • Osama H Alali, PhD · Senior Lecturer, Department of Orthodontics, School of Dentistry, University of Aleppo, Syria

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
11 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2011-07-31
Completion
2012-12-31

Countries

  • Syria

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01853995 on ClinicalTrials.gov